Cost-effectiveness of tablets of Posaconazole compared to oral Fluconazole or Itraconazole in the prevention of invasive fungal diseases among high-risk neutropenic patients with either acute myelogenous leukemia or myelodysplastic syndrome in Spain
Authors : De la Cámara R, Grau S, Jurado M, Sanz J, Paz S, Aragón B, Cavanillas R
Year: 2016
Congress: 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)